These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18297100)

  • 1. Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.
    Barrett TD; Yan W; Freedman JM; Lagaud GJ; Breitenbucher JG; Shankley NP
    Br J Pharmacol; 2008 Apr; 153(8):1650-8. PubMed ID: 18297100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
    Morton MF; Barrett TD; Yan W; Freedman JM; Lagaud G; Prendergast CE; Moreno V; Pyati J; Figueroa K; Li L; Wu X; Rizzolio M; Breitenbucher JG; McClure K; Shankley NP
    J Pharmacol Exp Ther; 2007 Nov; 323(2):562-9. PubMed ID: 17684117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.
    Latorre M; Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Herranz R; Del Río J; Cenarruzabeitia E
    Pharmacology; 2004 Oct; 72(2):68-76. PubMed ID: 15331911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin acts as an essential factor in the exacerbation of pancreatic bile duct ligation-induced rat pancreatitis model under non-fasting condition.
    Yoshinaga K; Washizuka M; Segawa Y
    Jpn J Pharmacol; 2000 Sep; 84(1):44-50. PubMed ID: 11043452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
    Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade.
    Niederau C; Borchard F; Lüthen R; Niederau M
    Hepatogastroenterology; 1996; 43(12):1442-53. PubMed ID: 8975946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
    Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
    Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
    Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats.
    Tachibana I; Shirohara H; Czako L; Akiyama T; Nakano S; Watanabe N; Hirohata Y; Otsuki M
    Pancreas; 1997 Mar; 14(2):113-21. PubMed ID: 9057182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
    Varga G; Kisfalvi K; D'Amato M; Scarpignato C
    J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
    Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
    Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK-A receptor induction and P38 and NF-kappaB activation in acute pancreatitis.
    Samuel I; Zaheer S; Nelson JJ; Yorek MA; Zaheer A
    Pancreatology; 2004; 4(1):49-56. PubMed ID: 14988658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction.
    Murayama KM; Samuel I; Toriumi Y; Solomon TE; Turkelson CM; Joehl RJ
    J Surg Res; 1993 Feb; 54(2):126-31. PubMed ID: 7683071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats.
    Seo SW; Jung WS; Piao TG; Hong SH; Yun KJ; Park RK; Shin MK; Song HJ; Park SJ
    World J Gastroenterol; 2007 Apr; 13(16):2298-304. PubMed ID: 17511027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the CCK receptor antagonist CR 1409 on bile reflux pancreatitis in the opossum.
    Larsen F; Schlarman D; Andrus CC; Kaminski DL
    Pancreas; 1991 May; 6(3):291-7. PubMed ID: 1713673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression.
    Miyasaka K; Ohta M; Tateishi K; Jimi A; Funakoshi A
    Pancreas; 1998 Mar; 16(2):114-23. PubMed ID: 9510132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction.
    Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
    J Surg Res; 1993 Feb; 54(2):132-5. PubMed ID: 8479170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
    Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
    J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet stimulation as a synergistic factor of aggravation in a pancreatic bile duct ligation-induced rat pancreatitis model.
    Yoshinaga K; Washizuka M; Segawa Y
    Biol Pharm Bull; 2000 Nov; 23(11):1318-22. PubMed ID: 11085359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.